Merrion Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,210
| Closed | -$397K | – | 95 |
|
2023
Q2 | $397K | Sell |
6,210
-600
| -9% | -$38.4K | 0.34% | 58 |
|
2023
Q1 | $472K | Sell |
6,810
-175
| -3% | -$12.1K | 0.45% | 44 |
|
2022
Q4 | $503K | Hold |
6,985
| – | – | 0.47% | 47 |
|
2022
Q3 | $496K | Sell |
6,985
-500
| -7% | -$35.5K | 0.49% | 45 |
|
2022
Q2 | $576K | Hold |
7,485
| – | – | 0.56% | 40 |
|
2022
Q1 | $546K | Hold |
7,485
| – | – | 0.4% | 53 |
|
2021
Q4 | $466K | Sell |
7,485
-1,000
| -12% | -$62.3K | 0.34% | 63 |
|
2021
Q3 | $502K | Buy |
8,485
+200
| +2% | +$11.8K | 0.38% | 49 |
|
2021
Q2 | $553K | Sell |
8,285
-500
| -6% | -$33.4K | 0.42% | 48 |
|
2021
Q1 | $554K | Hold |
8,785
| – | – | 0.46% | 48 |
|
2020
Q4 | $545K | Buy |
+8,785
| New | +$545K | 0.46% | 48 |
|